Reports about possible kidney problems, including renal failure, in people taking the diabetes drug exenatide (Byetta) have prompted changes to the drug’s prescribing information, the U.S. Food and Drug Administration said Monday. From April 2005 to October 2008, the FDA received 78 reports of kidney function problems in patients taking Byetta. Most of the problems [...]
Continue reading...
Tuesday, November 3, 2009
1 Comment